Literature DB >> 16644853

Rhythm control strategies for "symptomatic" persistent atrial fibrillation: is achieving sinus rhythm enough?

T R Betts.   

Abstract

A significant proportion of symptomatic patients who undergo DC cardioversion for persistent atrial fibrillation are unable to correctly perceive their rhythm shortly afterwards. Restoration of sinus rhythm does not necessarily result in improvement in symptoms.

Entities:  

Mesh：

Year:  2006        PMID： 16644853      PMCID： PMC1861134          DOI： 10.1136/hrt.2006.092650

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  11 in total

Review 1.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

2.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

3.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

4.  Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists.

Authors:  S Lévy; M Maarek; P Coumel; L Guize; J Lekieffre; J L Medvedowsky; A Sebaoun
Journal:  Circulation       Date:  1999-06-15       Impact factor: 29.690

5.  Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study. The Flecainide Supraventricular Tachycardia Study Group.

Authors:  A K Bhandari; J L Anderson; E M Gilbert; B L Alpert; R W Henthorn; A L Waldo; M T Cullen; R W Hawkinson; E L Pritchett
Journal:  Am Heart J       Date:  1992-08       Impact factor: 4.749

6.  Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery.

Authors:  Yaariv Khaykin; Nassir F Marrouche; Walid Saliba; Robert Schweikert; Dianna Bash; Michael S Chen; Michelle Williams-Andrews; Eduardo Saad; David J Burkhardt; Mandeep Bhargava; George Joseph; Antonio Rossillo; Demet Erciyes; David Martin; Andrea Natale
Journal:  Heart Rhythm       Date:  2004-05       Impact factor: 6.343

7.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

8.  Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation.

Authors:  A Nergårdh; M Frick
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

9.  Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia.

Authors:  R L Page; W E Wilkinson; W K Clair; E A McCarthy; E L Pritchett
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

Review 10.  Cardiac resynchronization therapy: caveat medicus!

Authors:  Mandeep R Mehra; Barry H Greenberg
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.